KBKathleen T. Bechtold

Kathleen T. Bechtold

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kathleen T. Bechtold has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Decision-making capacity in rehabilitation psychology practice: Historical, contemporary, and future perspectives.

    by Kathleen T. Bechtold, James W. Mikesell

    This article will review the historical underpinnings of informed consent and decisional capacity, current practices, and potential evolving future modifications or elaborations of decision-making practices in clinical settings. Ethical and legal foundations for informed consent for health care are reviewed. Contemporary issues with decision making, clinical capacity, and proxy decision making in rehabilitation psychology practice are discussed with a specific focus on health care decision making. As a subspecialist in psychology, a rehabilitation psychologist necessarily seeks to incorporate a working knowledge of its historical anchors while simultaneously seeking changes sensitive to honoring and advocating for the rights of the individuals whom they serve. The contributions of the disability rights movement have been immeasurable in ensuring that those most impacted with potential challenges to their right to self-determine their choices across a wide range of psycholegal issues are safeguarded. As rehabilitation psychologists, we must remain steadfast stewards and constructive supporters of those under our care through protecting and advocating for their rights. (PsycInfo Database Record (c) 2025 APA, all rights reserved).


  • Motivators and barriers to pursuing board certification: Survey results and future directions.

    by Suzzette M. Chopin, Erin E. Andrews, Kristen Jackson, Serina Hoover, Kathleen Bechtold

    This article reports survey results from the American Board of Rehabilitation Psychology (ABRP) on motivators and barriers to pursuing board certification and identifies ways the ABRP can reduce barriers. An electronic survey was sent to Division 22 and Academy of Rehabilitation Psychology listservs. Participants (N = 113) were primarily early career (37%), not board-certified (62%), and did not identify as a member of an underrepresented group (70%). Two independent coders conducted thematic analysis of qualitative data, identifying key themes. Discrepancies were resolved through discussion; final themes were agreed upon by consensus. Most nonboard-certified participants had considered specialty certification (93%). Of those reporting barriers (n = 64), primary barriers included work/time constraints (30%), lack of benefit (18%) and institutional support (15%), personal obstacles (14%), and financial considerations (13%). Motivational factors included professional reputation (42%), mentorship (38%), and institutional support (14%). Responses from those who identified as participants from diverse professional backgrounds emphasized the importance of mentorship, institutional and financial support, and elucidation of alternative pathways to certification. Despite strong interest in board certification, many individuals either do not initiate the process or begin but do not complete it. There also remains a lack of clarity regarding requirements and the process. The ABRP has implemented initiatives to address these concerns, including outlining alternative pathways, clarifying candidacy requirements, transitioning mentorship to the Academy of Rehabilitation Psychology, implementing educational outreach programs, providing individualized encouragement to candidates, increasing awareness of scholarship opportunities, and promoting nontraditional pathways to board certification. (PsycInfo Database Record (c) 2025 APA, all rights reserved).

  • Open Access

    Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [11C]DPA-713 PET

    by Jennifer M. Coughlin, Ting Yang, Alison W. Rebman, Kathleen T. Bechtold, Yong Du, William B. Mathews, Wojciech G. Lesniak, Erica A. Mihm, Sarah M. Frey, Erica S. Marshall, et al.

    The pathophysiology of post-treatment Lyme disease syndrome (PTLDS) may be linked to overactive immunity including aberrant activity of the brain’s resident immune cells, microglia. Here we used [11C]DPA-713 and positron emission tomography to quantify the 18 kDa translocator protein, a marker of activated microglia or reactive astrocytes, in the brains of patients with post-treatment Lyme disease symptoms of any duration compared to healthy controls. Genotyping for the TSPO rs6971 polymorphism was completed, and individuals with the rare, low affinity binding genotype were excluded. Data from eight brain regions demonstrated higher [11C]DPA-713 binding in 12 patients relative to 19 controls. [11C]DPA-713 PET is a promising tool to study cerebral glial activation in PTLDS and its link to cognitive symptoms.


  • Cognitive Decline in Post-treatment Lyme Disease Syndrome

    by Pegah Touradji, John N Aucott, Ting Yang, Alison W Rebman, Kathleen T Bechtold

    Patient-reported cognitive complaints are common in those with post-treatment Lyme disease syndrome (PTLDS). Objective evidence of cognitive impairment in this population is variable in part due to methodological variability in existing studies. In this study, we sought to use a systematic approach to characterizing PTLDS based on the most current consensus diagnosis. We further examined PTLDS-related cognitive decline, operationalized as a significant decline in cognitive test performance relative to premorbid cognitive ability. We enrolled a case series of 124 patients with confirmed PTLDS defined by Infectious Diseases Society of America-proposed case definition. Cognitive functioning was evaluated using standardized neuropsychological measures. The majority (92%) of participants endorsed some level of cognitive difficulty, yet 50% of the sample showed no statistically or clinically significant cognitive decline, 26% of the sample evidenced significant cognitive decline on measures of memory and variably on measures of processing speed, and 24% of the sample were excluded from analyses due to suboptimal test engagement. The current findings are consistent with the literature showing that the most robust neurocognitive deficit associated with PTLDS is in verbal memory and with variable decline in processing speed. Compared to population normative comparison standards, PTLDS-related cognitive decline remains mild. Thus, further research is needed to better understand factors related to the magnitude of subjective cognitive complaints as well as objective evidence of mild cognitive decline.


  • Behavioural interventions for enhancing life participation in behavioural variant frontotemporal dementia and primary progressive aphasia

    by Kathleen B. Kortte, Emily J. Rogalski

    Primary progressive aphasia (PPA) and behavioural-variant frontotemporal dementia (bvFTD) are clinical syndromes under the umbrella term ‘frontotemporal dementia’ (FTD) and are caused by a neurodegenerative disease with an onset most typically in the productive years of adulthood. The cognitive and behavioural impairments associated with FTD interfere with successful engagement in typical life roles, such as parenting, working, and maintenance of interpersonal relationships. There are currently no treatments to stop or slow the degenerative process and there are only very limited medication options for the management of the cognitive-behavioural symptoms. However, alternative, non-pharmacological interventions may offer significant benefit to the quality of life of the diagnosed individual. The goal of this paper is to provide an overview of the approaches available through neurorehabilitation and community-based services that facilitate successful engagement in life activities and promote optimal quality of life for the individuals and families living with FTD. It is hoped that as medical providers become more familiar with behavioural interventions, referrals for services will increase thereby allowing individuals with FTD and their caregivers to learn ways to adapt, adjust, and participate in life to the fullest despite the impairments from this progressive disease.


  • Recent advances in the understanding of neglect and anosognosia following right hemisphere stroke

    by Kathleen Kortte, Argye E. Hillis

    This article highlights the latest findings regarding the cognitive-behavioral syndromes of neglect and anosognosia for hemiplegia that occur following right hemisphere stroke. We review papers published in the past 2 years pertaining to neurophysiology, assessment, and intervention for these two syndromes.


  • The Hopkins Rehabilitation Engagement Rating Scale: Development and Psychometric Properties

    by Kathleen B. Kortte, Lara D. Falk, Renan C. Castillo, Doug Johnson-Greene, Stephen T. Wegener